Strauss Borrelli PLLC, a leading data breach law firm, is investigating Cambrex Corporation regarding its recent data breach. The Cambrex data breach involved sensitive personal identifiable information and protected health information belonging to over 2,000 individuals.
ABOUT CAMBREX CORPORATION:
Cambrex is a leading global contract development and manufacturing organization based in New Jersey.2 Founded in 1981, Cambrex delivers drug substance, drug product, and analytical services across the entire drug life cycle.2 Today, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing.3 Headquartered in East Rutherford, New Jersey, Cambrex has 14 locations across North America and Europe and employs over 2,000 individuals.
WHAT HAPPENED?
Recently, Cambrex discovered that it had experienced a data breach in which the sensitive personal identifiable information and protected health information in its systems may have been accessed. Through its investigation, Cambrex determined that an unauthorized actor may have accessed this sensitive information on November 8, 2023. On May 20, 2024, Cambrex began notifying individuals whose information may have been impacted. The type of information potentially exposed includes:
- Name
- Social Security number
- Driver’s license information
- Financial account information
- Credit or debit card numbers
- Medical record information
If you received a breach notification letter from Cambrex Corporation:
We would like to speak with you about your rights and potential legal remedies in response to this data breach. Please fill out the form, below, or contact us at 872.263.1100 or sam@straussborrelli.com.
